Spirometer Global Market Report 2024

The global spirometer market has grown strongly in recent years. It will grow from $1.15 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the historical period can be primarily attributed to several factors, including the heightened prevalence of respiratory diseases, an increased focus on preventive healthcare measures, demographic shifts towards an aging population, and the advancement of clinical research emphasizing evidence-based practices in respiratory health.

The global spirometer market is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be linked to several factors, including a shift towards home healthcare services, the continuation of clinical research initiatives, evolving medical reimbursement policies, and increased focus on occupational health monitoring. Additionally, major trends projected for this period encompass the rise of remote monitoring and telemedicine services, efforts towards enhancing patient engagement and empowerment, integration of digital health technologies, emphasis on personalized medicine and patient-centric care approaches, as well as heightened market competition driving innovation within the healthcare sector.

The rising prevalence of chronic respiratory diseases is anticipated to fuel the demand for the spirometer market. Chronic respiratory diseases, including conditions such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung diseases, are characterized by persistent issues with the airways and lungs. Portable spirometers, approved for diagnosing COPD, play a crucial role in the assessment and management of these conditions. For instance, data from July 2022 reported by the Australian Institute of Health and Welfare indicates that 30% of Australians reported having chronic respiratory conditions. Among the estimated 7.5 million Australians with these conditions, 20% had allergic rhinitis ('hay fever'), 11% had asthma, and 8.0% had chronic sinusitis. The increasing prevalence of chronic respiratory diseases is a key driver contributing to the growing demand for spirometers in the market.

The growth of the aging population is expected to drive the demand for spirometers as well. The aging population, consisting of individuals in their later stages of life, creates a greater need for spirometry testing, particularly as healthcare providers focus on managing respiratory health in older individuals. Data from October 2022 released by the World Trade Organization highlights a significant increase in the proportion of the population aged 60 and above, reaching 1.4 billion in 2021. Projections indicate that by 2050, the global population of adults aged 60 and above will double to 2.1 billion, with the number of people aged 80 or more predicted to triple, reaching 426 million. The growing aging population is a significant factor contributing to the rising demand for spirometers in the market.

Technological advancement emerges as a key trend in the spirometer market, with major players focusing on innovative technologies to gain a competitive edge. Notably, Cipla Ltd., an India-based pharmaceutical company, launched Spirofy in November 2021. Spirofy is a pneumatic-based portable and wireless spirometer designed with advanced features such as high result accuracy and individual patient safety using bacterial viral filters (BVF). Its wireless and portable nature, coupled with good battery backup, makes it suitable for various settings, including outdoor camps, remote areas with power shortages, or providing physicians with flexibility and ease of use. Technological innovation is a crucial aspect of market players' strategies to meet the evolving needs of healthcare professionals and patients in the spirometer market.

Major players in the spirometer market are placing a strong emphasis on product innovation, exemplified by advancements such as AioCare. AioCare is a comprehensive system designed for monitoring and treating lung diseases, comprising a portable spirometer linked to a smartphone app and an online panel for accessing test results. This device facilitates complete spirometry tests in a healthcare setting, including workflows for bronchial responsiveness. An illustration of this focus on innovation is seen in the launch of the AioCare mobile spirometry system by Vyaire Medical in March 2021. Introduced across more than 15 countries in Europe, the Middle East, and Australia, this clinically proven technology builds on Vyaire’s extensive expertise in respiratory diagnostics. AioCare enables physicians to promptly and accurately diagnose pulmonary diseases, such as asthma and COPD, with results comparable to hospital-grade spirometers. Additionally, it supports high-quality patient monitoring through advanced digital connectivity in home settings.

In a strategic move to enhance their portfolio, CAIRE Inc., a U.S.-based respiratory device manufacturer, acquired MGC Diagnostics Holdings, Inc. in November 2022. This acquisition brings a range of pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and associated consumables into CAIRE Inc.'s offerings. MGC Diagnostics Holdings, Inc., known for its expertise in developing non-invasive diagnostic systems for detecting and managing cardiorespiratory diseases, aligns with CAIRE Inc.'s commitment to expanding and diversifying its product range in the spirometer market. These initiatives highlight the industry's dedication to continuous innovation and strategic partnerships to meet the evolving needs of healthcare professionals and patients in the spirometer market.

Major companies operating in the spirometer market report are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sdi Diagnostics Inc., Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Philips Healthcare, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.

North America was the largest region in the spirometer market share in 2023. The regions covered in the spirometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Different types of spirometers include hand-held, tabletop, and desktop variants. Hand-held spirometers are particularly employed in longitudinal epidemiological studies to measure and monitor forced expiratory volume. The hand-held segment of the spirometer market facilitates at-home lung testing without necessitating a visit to a healthcare professional. The technology within a spirometer typically involves volume measurement, flow measurement, and peak flow measurement. Spirometer products encompass the device itself, consumables, accessories, and associated software. These devices find application in conditions such as asthma, COPD, cystic fibrosis, pulmonary fibrosis, and various other respiratory conditions. They are utilized across diverse settings including hospitals, clinics, and in home healthcare scenarios.

This report provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.